Triazacryptand Chromoionophores for Potassium Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring potassium ion (K+) levels in biological samples, particularly in the extracellular space of the brain, face challenges due to the need for accurate, real-time, and non-invasive techniques that are sensitive to potassium while being insensitive to sodium and pH variations, and are not suitable for in vivo applications.
Innovation Solution
Development of chromoionophore compounds comprising a triazacryptand (TAC) K+ ionophore conjugated to xanthylium dyes or other chromophoric moieties, providing dual wavelength detection for absolute potassium concentration determination, which are water-soluble, membrane-impermeant, and non-toxic, allowing for in vivo imaging of potassium levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If microelectrodes are used for potassium measurement, then measurement accuracy is improved, but device complexity and invasiveness increase
Solution Approach 1:
The patent replaces the mechanical/electrical microelectrode system with a fluorescent optical system. The chromoionophore compounds emit fluorescent signals that can be detected optically, eliminating the need for complex microelectrode fabrication and electrical measurement systems while maintaining measurement capability.
Solution Approach 2:
The patent utilizes fluorescent color changes of chromoionophore compounds in response to potassium binding. The compounds exhibit wavelength-specific fluorescent emission that changes upon potassium ion binding, enabling optical detection of potassium concentration without mechanical electrodes.
2Measurement precision
If existing fluoroionophores are used, then potassium detection capability is provided, but selectivity against sodium and pH sensitivity deteriorate
Solution Approach 1:
The patent designs chromoionophore compounds with specific local structural features - triazacryptand rings with particular substituent patterns (R1-R5 groups) that create a binding site optimized for potassium ion size and charge distribution. This local structural optimization provides high potassium selectivity over sodium while maintaining fluorescent detection capability.
Solution Approach 2:
The patent creates composite chromoionophore molecules combining the triazacryptand ionophoric moiety with fluorescent chromophore groups and hydrophilic polymers. This composite structure integrates potassium-selective binding with fluorescent signaling and water solubility, achieving multiple performance requirements simultaneously.
3Measurement precision
If crown ether ionophores are used, then potassium binding is achieved, but water solubility and membrane impermeability deteriorate
Solution Approach 1:
The patent conjugates hydrophilic polymer chains (such as polyethylene glycol or dextran) to the triazacryptand-chromophore core structure. This composite approach maintains the potassium-binding capability of the cryptand while the hydrophilic polymer chains provide water solubility and prevent membrane permeation, enabling in vivo extracellular space imaging.
4Illumination intensity
If short wavelength excitation is used, then fluorescence detection is possible, but tissue penetration and imaging depth deteriorate
Solution Approach 1:
The patent selects chromophoric moieties with absorption maxima in the green-to-red region (500-650 nm) rather than UV/blue regions. This parameter change in excitation wavelength provides both adequate fluorescence signal intensity and improved tissue penetration depth, enabling in vivo imaging through scattering and absorption characteristics of biological tissue.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The chromoionophore compounds enable precise, real-time measurement of potassium levels with high selectivity and sensitivity, minimizing interference from sodium and pH changes, and are suitable for in vivo use, facilitating the detection of potassium waves in the brain extracellular space.
Implementation Method 1
a triazacryptand (TAC) K+ ionophore conjugated to at least a first chromophoric moiety
Implementation Method 2
a fluorophore portion, which provides a fluorescent signal in response to the ion-binding event
Data Source
AI summary
The invention provides chromoionophore compounds comprising a triazacryptand (TAC) K+ ionophore conjugated to at least a first chromophoric moiety (e.g., xanthylium dyes and derivatives thereof). In related embodiments, the chromoionophore compounds further comprise a second chromophoric moiety which is insensitive to potassium binding by the TAC ionophore, thus providing for dual wavelength detection and absolute determination of K+ concentration. The invention further provides methods and kits for the determination of K+ concentrations in biological systems, either in vitro or in vivo, using embodiments of inventive chromoionophores.